Nirmala Induru
Psychiatry · Marrero, LANPI 1124157417
Payments from drug & device makers
Across 127 payments — averaging $17.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$406
- Johnson & Johnson$360
- Neurocrine Biosciences, Inc.$227
- Lundbeck LLC$222
- Alkermes, Inc.$175
- Sunovion Pharmaceuticals Inc.$173
- plus $618 from 10 others
What the payments were for
- Food & beverage$2,180100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $406 |
| Johnson & Johnson | 22 | $360 |
| Neurocrine Biosciences, Inc. | 11 | $227 |
| Lundbeck LLC | 13 | $222 |
| Alkermes, Inc. | 8 | $175 |
| Sunovion Pharmaceuticals Inc. | 14 | $173 |
| Otsuka America Pharmaceutical, Inc. | 8 | $156 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $133 |
| E.r. Squibb & Sons, L.L.C. | 7 | $117 |
| Vanda Pharmaceuticals Inc. | 3 | $55 |
| Teva Pharmaceuticals USA, Inc. | 3 | $45 |
| Noven Therapeutics, LLC | 2 | $31 |
| Indivior Inc. | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Eisai Inc. | 1 | $15 |
How this compares
$2,180 in reported general payments places this provider in the 70th percentile of 474 psychiatry providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 61 | $153,395 |
| Abilify MaintenaAripiprazole | 35 | $104,170 |
| VraylarCariprazine Hcl | 18 | $28,164 |
| Seroquel XrQuetiapine Fumarate | 13 | $5,527 |
| Aripiprazole | 62 | $4,534 |
| Lurasidone Hcl | 43 | $3,857 |
| Divalproex Sodium ErDivalproex Sodium | 80 | $2,612 |
| Oxcarbazepine | 52 | $1,693 |
| Clozapine | 28 | $1,295 |
| Haloperidol Decanoate | 36 | $1,255 |
| Sertraline Hcl | 151 | $1,215 |
| Olanzapine | 72 | $1,192 |
| Quetiapine Fumarate | 76 | $1,004 |
| Mirtazapine | 42 | $832 |
| Paliperidone ErPaliperidone | 12 | $819 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $360 | $153,39561 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $156 | $104,17035 claims |
| AbbVieVraylar | $406 | $28,16418 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 474 psychiatry providers in Louisiana.
Other psychiatry in Marrero
- Phuong NguyenMarrero$11K
- Kashinath YadalamLake Charles$3.8M
- Guy BrannonShreveport$1.4M
- Patrick HayesLake Charles$853K
- Maria CruseThibodaux$522K
- Larry WarnerBaton Rouge$495K
- Gregory BrownShreveport$495K
- Arwen PodestaNew Orleans$466K
- Jasjit SinghShreveport$420K
- Aruna GullapalliMonroe$287K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.